fbpx

Bayer AG

BAYGnEUR.S

$68.21

Closing

1D

YTD

BAYGnEUR

BBG001S67NP8

Exchange

Sector

Market cap

$20.96B

Volume

39,750

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$20.96B

Analysts' Rating

HOLD

Price Target (Mean)

28.71

Total Analysts

21

P/E

Operating Margin

31.11%

Beta

Revenue Growth

-3.62%

52 week high

$

52 week low

$

Div. Yield

0.53%

EPS Growth

-75.19

Company Profile

Bayer AG is a German-based life science company. The Company’s segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.